Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cancers (Basel) ; 15(9)2023 May 08.
Article in English | MEDLINE | ID: mdl-37174123

ABSTRACT

Hematologic malignancies are a group of neoplastic conditions that can develop from any stage of the hematopoiesis cascade. Small non-coding microRNAs (miRNAs) play a crucial role in the post-transcriptional regulation of gene expression. Mounting evidence highlights the role of miRNAs in malignant hematopoiesis via the regulation of oncogenes and tumor suppressors involved in proliferation, differentiation, and cell death. In this review, we provide current knowledge about dysregulated miRNA expression in the pathogenesis of hematological malignancies. We summarize data about the clinical utility of aberrant miRNA expression profiles in hematologic cancer patients and their associations with diagnosis, prognosis, and the monitoring of treatment response. Moreover, we will discuss the emerging role of miRNAs in hematopoietic stem cell transplantation (HSCT), and severe post-HSCT complications, such as graft-versus-host disease (GvHD). The therapeutical potential of the miRNA-based approach in hemato-oncology will be outlined, including studies with specific antagomiRs, mimetics, and circular RNAs (circRNAs). Since hematologic malignancies represent a full spectrum of disorders with different treatment paradigms and prognoses, the potential use of miRNAs as novel diagnostic and prognostic biomarkers might lead to improvements, resulting in a more accurate diagnosis and better patient outcomes.

2.
Microorganisms ; 11(1)2022 Dec 31.
Article in English | MEDLINE | ID: mdl-36677399

ABSTRACT

Pre-clinical models and clinical studies highlight the significant impact of the host-microbiota relationship on cancer development and treatment, supporting the emerging trend for a microbiota-based approach in clinical oncology. Importantly, the presence of polymorphic microbes is considered one of the hallmarks of cancer. The epigenetic regulation of gene expression by microRNAs affects crucial biological processes, including proliferation, differentiation, metabolism, and cell death. Recent evidence has documented the existence of bidirectional gut microbiota-microRNA interactions that play a critical role in intestinal homeostasis. Importantly, alterations in microRNA-modulated gene expression are known to be associated with inflammatory responses and dysbiosis in gastrointestinal disorders. In this review, we summarize the current findings about miRNA expression in the intestine and focus on specific gut microbiota-miRNA interactions linked to intestinal homeostasis, the immune system, and cancer development. We discuss the potential clinical utility of fecal miRNA profiling as a diagnostic and prognostic tool in colorectal cancer, and demonstrate how the emerging trend of gut microbiota modulation, together with the use of personalized microRNA therapeutics, might bring improvements in outcomes for patients with gastrointestinal cancer in the era of precision medicine.

3.
Int J Mol Sci ; 23(1)2021 Dec 22.
Article in English | MEDLINE | ID: mdl-35008529

ABSTRACT

BACKGROUND: Dissemination of breast cancer (BC) cells through the hematogenous or lymphogenous vessels leads to metastatic disease in one-third of BC patients. Therefore, we investigated the new prognostic features for invasion and metastasis. METHODS: We evaluated the expression of miRNAs and epithelial-to-mesenchymal transition (EMT) genes in relation to CDH1/E-cadherin changes in samples from 31 patients with invasive ductal BC including tumor centrum (TU-C), tumor invasive front (TU-IF), lymph node metastasis (LNM), and CD45-depleted blood (CD45-DB). Expression of miRNA and mRNA was quantified by RT-PCR arrays and associations with clinico-pathological characteristics were statistically evaluated by univariate and multivariate analysis. RESULTS: We did not verify CDH1 regulating associations previously described in cell lines. However, we did detect extremely high ZEB1 expression in LNMs from patients with distant metastasis, but without regulation by miR-205-5p. Considering the ZEB1 functions, this overexpression indicates enhancement of metastatic potential of lymphogenously disseminated BC cells. In CD45-DB samples, downregulated miR-205-5p was found in those expressing epithelial and/or mesenchymal markers (CTC+) that could contribute to insusceptibility and survival of hematogenously disseminated BC cells mediated by increased expression of several targets including ZEB1. CONCLUSIONS: miR-205-5p and potentially ZEB1 gene are promising candidates for markers of metastatic potential in ductal BC.


Subject(s)
Breast Neoplasms/genetics , Carcinoma, Ductal, Breast/genetics , Down-Regulation/genetics , MicroRNAs/genetics , Up-Regulation/genetics , Zinc Finger E-box-Binding Homeobox 1/genetics , 3' Untranslated Regions/genetics , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Epithelial-Mesenchymal Transition/genetics , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , Lymphatic Metastasis/genetics , Lymphatic Metastasis/pathology , Middle Aged
4.
Int J Mol Sci ; 22(1)2020 Dec 24.
Article in English | MEDLINE | ID: mdl-33374439

ABSTRACT

The current guidelines for diagnosis, prognosis, and treatment of endometrial cancer (EC), based on clinicopathological factors, are insufficient for numerous reasons; therefore, we investigated the relevance of miRNA expression profiles for the discrimination of different EC subtypes. Among the miRNAs previously predicted to allow distinguishing of endometrioid ECs (EECs) according to different grades (G) and from serous subtypes (SECs), we verified the utility of miR-497-5p. In ECs, we observed downregulated miR-497-5p levels that were significantly decreased in SECs, clear cell carcinomas (CCCs), and carcinosarcomas (CaSas) compared to EECs, thereby distinguishing EEC from SEC and rare EC subtypes. Significantly reduced miR-497-5p expression was found in high-grade ECs (EEC G3, SEC, CaSa, and CCC) compared to low-grade carcinomas (EEC G1 and mucinous carcinoma) and ECs classified as being in advanced FIGO (International Federation of Gynecology and Obstetrics) stages, that is, with loco-regional and distant spread compared to cancers located only in the uterus. Based on immunohistochemical features, lower miR-497-5p levels were observed in hormone-receptor-negative, p53-positive, and highly Ki-67-expressing ECs. Using a machine learning method, we showed that consideration of miR-497-5p expression, in addition to the traditional clinical and histopathologic parameters, slightly improves the prediction accuracy of EC diagnosis. Our results demonstrate that changes in miR-497-5p expression influence endometrial tumorigenesis and its evaluation may contribute to more precise diagnoses.


Subject(s)
Endometrial Neoplasms/metabolism , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Adenocarcinoma, Clear Cell/genetics , Adenocarcinoma, Mucinous/genetics , Adult , Aged , Aged, 80 and over , Carcinoma/genetics , Carcinoma/metabolism , Carcinoma, Endometrioid/metabolism , Cystadenocarcinoma, Serous/genetics , Endometrial Neoplasms/diagnosis , Endometrial Neoplasms/genetics , Endometrium/metabolism , Female , Humans , Machine Learning , Middle Aged , Prognosis
5.
J Environ Sci Health B ; 54(6): 525-532, 2019.
Article in English | MEDLINE | ID: mdl-31046581

ABSTRACT

The aim of our study is to determine microbial contamination, antibacterial and antioxidant activities of 14 pollen samples of Corylus avellana collected from different locations in Slovakia. Microbiological analysis was carried out in two steps: microbiological assays and studies of antibacterial activity of pollen extracts. The antimicrobial properties of pollen extracts were carried out with the disc-diffusion method. Methanol (70%), ethanol (70%) and distilled water were used for pollen extracts. Five strains of bacteria such as gram-negative (Salmonella enterica subsp. enterica CCM 3807, Escherichia coli CCM 2024, and Yersinia enterocolitica CCM 5671) and gram-positive (Staphylococcus aureus CCM 2461 and Bacillus thuringiensis CCM 19T) were tested. Antioxidant activity of pollen extracts was determined by the DPPH method. Bacterial analysis includes the determination of the total bacterial count ranged from 4.08 to 4.61 log CFU g-1, mesophilic aerobic bacteria ranged from 3.40 to 4.89 log CFU g-1, mesophilic anaerobic bacteria ranged from 3.20 to 4.52 log CFU g-1, coliform bacteria ranged from 3.30 to 4.55 log CFU g-1, yeasts and filamentous fungi ranged from 3.00 to 3.56 log CFU g-1. Microscopic filamentous fungi Aspergillus spp., Alternaria spp., Penicillium spp., Cladosporium spp., Rhizopus spp., and Paecylomyces spp. were isolated from hazelnut pollen. Yersinia enterocolitica was the most sensitive strain among ethanolic and methanolic pollen hazelnut extracts. Staphylococcus aureus was the most sensitive strain against aqueous hazelnut pollen extracts. We determined the following sensitivity against ethanol pollen extracts respectively: Yersinia enterocolitica > Salmonella enterica > Staphylococcus aureus > Bacillus thuringiensis > Escherichia coli. Methanol pollen extracts had shown following sensitivity: Yersinia enterocolitica > Salmonella enterica > Escherichia coli > Staphylococcus aureus > Bacillus thuringiensis. Aqueous extracts had shown the following sensitivity: Staphylococcus aureus > Salmonella enterica > Escherichia coli > Bacillus thuringiensis > Yersinia enterocolitica. Hazelnut pollen extracts have over 82% antioxidant capacity in samples from non-urban zones. An elevated level of antioxidant potential in the pollen is determined by its biological properties conditioned by biologically active substances. DPPH method allowed characterizing pollen as a source of antioxidants.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology , Corylus/microbiology , Plant Extracts/pharmacology , Pollen/microbiology , Bacteria/drug effects , Corylus/chemistry , Microbial Sensitivity Tests , Microbiota , Plant Extracts/chemistry , Slovakia , Urbanization
6.
Wiad Lek ; 70(1): 139-143, 2017.
Article in English | MEDLINE | ID: mdl-28343209

ABSTRACT

INTRODUCTION: The present paper examines the linguistic status of terminological collocations in medical Latin and English, discusses the most productive term-formation models and ways of Latin-English translation. AIM: The authors aim to provide the comparative analysis of Latin and English terminological collocations and suggest their classification in terms of the idiomaticity level and semantic valency. MATERIALS AND METHODS: The research is based on the corpus of terminological collocations in Latin and English medical discourse using structural, etymological, typological, comparative methods, as well as the method of semantic analysis and conceptual metaphor theory. RESULTS: The research has resulted in the delineation of the following groups of terminological collocations in medical Latin and English: (1) terminological collocations with lower degree of idiomaticity - analytical units whose semantics correlates with the amount of free meanings of the components; (2) terminological collocations with semantic cohesion of the components due to metaphorical nature of the terminological element with active / passive valency; (3) clinical idioms - terminological collocations with higher degree of idiomaticity. Within the latter group, we suggest to discern eponymic, toponymic, zoomorphic, botanic and mythonimic subtypes of terminological collocations. CONCLUSIONS: A promising area of future research is the development of bilingual explanatory dictionaries with Latin and English equivalents of terminological collocations, as well as the information about the semantics of their components.


Subject(s)
Semantics , Terminology as Topic , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...